glp 1 drugs vs metformin TrimRX Comparing Glucagon‐like peptide‐1 receptor agonists
Description
These patterns consistently lead to poor outcomes
Eating disorders exist on a wide-spectrum, but most are at least partially characterized by some form of food restriction
Clinical trials demonstrated 13.7 percent average body weight loss at 72 weeks, with many participants exceeding 15 percent
Is Semaglutide GLP-1 Safe for Weight Loss
[PubMed ID: 17244786]
